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ConvergenceG protein-coupled receptors (GPCRs) are a large, biomedically important family of proteins, and the recent
explosion of new high-resolution structural information about them has provided an enormous opportunity
for computational modeling to make major contributions. In particular, molecular dynamics simulations have
become a driving factor in many areas of GPCR biophysics, improving our understanding of lipid–protein
interaction, activation mechanisms, and internal hydration. Given that computers will continue to get faster
and more structures will be solved, the importance of computational methods will only continue to grow,
particularly as simulation research is more closely coupled to experiment..
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G protein-coupled receptors (GPCRs) are arguably the most
important family of proteins currently studied. They are not only
numerous—GPCRs are the largest family of proteins in the humangenome—but exceptionally important biomedically. Indeed, it has
been estimated that more than a quarter of novel drugs target GPCRs
[1–3]. As a result, GPCRs have drawn an enormous amount of scientiﬁc
attention, applying the entire arsenal of molecular biology, biochem-
istry, and biophysics. However, GPCRs, like many integral membrane
proteins, are difﬁcult to handle experimentally; they require a
membrane-mimetic environment to remain folded. Thus, ﬁnding
conditions to overexpress and purify them remains challenging. As a
1869A. Grossﬁeld / Biochimica et Biophysica Acta 1808 (2011) 1868–1878result, molecular level biophysical characterization of GPCR function
lags behind larger-scale functional approaches, yet this detailed
information will be needed to rationalize efforts in drug design and
other areas of GPCR research.
In 2000, the ﬁeld took a major step forward with the publication of
the ﬁrst high-resolution crystal structure for a GPCR, dark-state
bovine rhodopsin [4]. This landmark achievement gave us the ﬁrst
atomic level view of GPCR structure; however, the fact remains that
rhodopsin is a somewhat unusual GPCR, with a covalently bound (as
opposed to diffusable) ligand, and as such it was not clear how
applicable the insights from the structure would be to other GPCRs,
even those in the same subfamily.
In the next few years, several new structures were solved for
inactive rhodopsin [5–8], but it was not until 2007 that a second GPCR
crystal structure, this time for the β2-adrenergic receptor (B2AR), was
published [9–11]. This was followed in rapid succession by two more
GPCRs: the A2A-adenosine receptor (A2A) [12] and the β1-adrenergic
receptor (B1AR) [13]. More recently, there have been a number of
structures that purport to capture a more “active” form of rhodopsin,
by crystallizing opsin (rhodopsin in the apo form, without its retinal
ligand) with [14] or without a G protein analog bound [15], or in the
presence of all-trans retinal, the agonist form of the ligand [16].
Finally, in 2010 new structures for the dopamine [17] and chemokine
[18] receptors were published.
This explosion of new structural information created an opportu-
nity for computational methods to make major contributions to our
understanding of GPCR function and dynamics. The rhodopsin
structures and, more recently, the structures of B2AR, B1AR, and
A2A have been used as starting points for a large variety of molecular
simulation projects. In this review, we will attempt to summarize the
work in this ﬁeld, putting the results in the broader context of GPCR
function. We will not attempt a more general review of the GPCR ﬁeld
as a whole or even to review the impact of the X-ray structures [19–
21], as this is too large a task for a single review.Moreover, wewill not
attempt to cover all of the computational approaches applied to
GPCRs [22]; in order to control the scope of this manuscript, we will
largely exclude structure prediction, ligand docking, and other related
methods, in favor of a focus on more quantitative methods, primarily
molecular dynamics (MD) simulations. Finally, this manuscript is not
intended as an introduction to the ﬁeld of GPCRs; although we will
cover some of the basics, we strongly suggest beginning readers also
consult the many review articles cited here. Basic GPCR behavior is
also covered in most standard textbooks on molecular cell biology
[23].
When referring to speciﬁc residues in GPCRs, we will use the
Ballesteros–Weinstein notation; in each helix, the most conserved
residue is numbered 50, and all other residues count from there [24].
Thus, the tryptophan residue involved in the rotamer toggle to
activation is Trp-265 in rhodopsin, found on helix 6, would be shown
as Trp-2656.48 in a discussion of rhodopsin, or as just Trp6.48 if we
were discussing the properties of that position independent of any
single protein. Although including the residue number for a speciﬁc
protein is not strictly part of Ballesteros–Weinstein notation, it will
simplify comparisons to other papers where the notation is not used.
For loops, where the residues are not well conserved, we will simply
include the loop identiﬁer, e.g., “ECL2” for extracellular loop 2.
2. Rhodopsin
Rhodopsin, the dimlight receptor in themammalian vision system,
in many ways functions as the hydrogen atom for GPCRs. It has been
studied extensively, with almost 8000 papers published on it
according to PubMed, starting with Wald and Clark in 1937 [25]; it
was actually discovered even earlier, in the late 1800s [26]. Part of the
reason rhodopsin has been so heavily studied is its ready abundance;
in contrast to other GPCRs, which are typically found in very lowconcentrations in the cell, rhodopsin is found in high concentrations
in the rod outer segment disks of the mammalian vision system. In
general, it is also more tolerant of high lipid–protein ratios than other
GPCRs, facilitating its study by biophysical methods, including
ﬂuorescence, infrared spectroscopy, chemical labeling, electron
paramagnetic resonance, and solid state NMR [27]. This also facilitated
the protein's crystallization and led to the ﬁrst high-resolution GPCR
structures in 2000 [4–8,28].
As a direct result, rhodopsin has also been heavily studied using
MD simulations, far more so than the other GPCRs. In particular, a
signiﬁcant amount of work has focused on the role of lipid–protein
interactions in modulating rhodopsin function, including the possible
functional role of oligomers, and on the conformational changes
undergone during the activation process.
2.1. Lipid–protein interactions in the dark state
2.1.1. Polyunsaturated ω-3 lipids
The environment surrounding a biomolecule is critical to its
behavior, stabilizing the formation of a native state and modulating
the ﬂuctuations that drive function. For membrane proteins, this
manifests in the ways that the lipid composition of a bilayer alters the
stability and efﬁciency proteins embedded in it [29–33].
Rhodopsin is a particularly interesting example of this phenom-
enon. Its native environment, the rod outer segment (ROS) mem-
branes of rod cells of themammalian vision system, have very unusual
lipid compositions. First, they are highly enriched in polyunsaturated
ω-3 fatty acids [34]; given that natural lipids nearly always have a
saturated fatty acid in the sn-1 position, the results suggest that most
lipids have a polyunsaturated chain. This is remarkable considering
that mammals cannot synthesize ω-3 fatty acids themselves, and the
overall abundance of ω-3s at the organism level is more likely 5%.
Second, the cholesterol concentration is quite high in ROSmembranes
but is not uniform [34]. Rather, it is very high in immature ROS disks
and gradually drops as the disks migrate toward the top of the stack.
This clearly indicates that the cell is carefully controlling the ROS
membranes' lipid composition, and since almost all of the protein in
those membranes is rhodopsin it is unsurprising that experimental
work in vitro shows that both ω-3s and cholesterol have signiﬁcant
effects on rhodopsin's activity. In particular, polyunsaturated lipids
enhance rhodopsin function, pushing the Meta-I/Meta-II equilibrium
toward the active Meta-II state [35], while cholesterol has the
opposite effect [36].
Given that both cholesterol and ω-3s alter the bulk properties of
liquid crystalline membranes—cholesterol increases order while ω-3s
are highly disordered [37], it would be interesting to know the
mechanism by which they each modulate rhodopsin. Speciﬁcally, do
they form speciﬁc interactions with the protein, or is their effect due
just to their effects on membrane elasticity or other bulk properties?
For the polyunsaturated lipids, the ﬁrst evidence from simulations
came from a molecular dynamics simulation of rhodopsin in a 1-
stearoyl-2-docosahexaenoyl phosphatidylcholine (SDPC) membrane
by Feller et al. [38]. Although the simulations were relatively short
(12.5 ns), there was a clear preference for the ω-3 docosahexanoyl
chains to interact with the protein, with a concomitant exclusion of
the saturated stearoyl chains.
Grossﬁeld and coworkers followed this up by considering the
dynamics of rhodopsin in a realistic membrane composition contain-
ing SDPC, SDPE (phosphatidylethanolamine), and cholesterol [39,40].
The presence of multiple lipid species meant that lateral reorganiza-
tion of the membrane, which occurs on the microsecond scale or
slower, had to be taken into account. Accordingly, they chose to
perform 26 separate 100 ns simulations (as opposed to a single long
trajectory), rebuilding the bilayer from scratch each time to ensure
that a number of truly independent bilayer conformations were
explored. The results were consistent with those seen previously [38];
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enhanced but the improvement in sampling allowed more detailed
analysis. In particular, the paper identiﬁed eight distinct sites on the
protein surface that repeatedly formed tight interactions with
docosahexaenoyl chains, consistent with solid state NMR results
suggesting speciﬁc binding [40,41]. Later analysis of the statistics of
chain states suggested that the preference for polyunsaturated chains
at the protein surface was entropically driven, in that the ω-3 chains
experience a far lower entropic penalty than saturated chains when
partitioning to the protein surface [42]. A smaller number of less
populated clusters were identiﬁed for stearoyl chains and cholesterol.
Although previous simulation work suggested that cholesterol is
largely excluded from the protein surface [39,40], a more recent 1.6 μs
simulation of rhodopsin suggested that cholesterol–protein interac-
tions may modulate the kink angles of helix 7 [43].
There is also signiﬁcant evidence that the headgroup composition
can also affect rhodopsin function, and that in particular PE head-
groups enhance rhodopsin function [44,45]. However, the time scale
of lateral reorganization appears too long for this to be directly
addressed by all-atom simulations at this time [40].
2.1.2. Oligomerization
Over the last few years, the role of oligomerization in GPCR
function has been intensely debated [46]. On one hand, there is
signiﬁcant experimental evidence for homo- and hetero-dimerization
under some conditions [47–53]. Similarly, computational work from
Filizola and coworkers has argued that rhodopsin forms dimers [54]
and that other GPCRs form heterodimers [55]. Along the same lines,
coarse-grained (CG) molecular dynamics simulations of rhodopsin in
a series of lipid bilayers with varying hydrophobic thicknesses clearly
demonstrated the role of lipid–protein interactions in modulating
oligomerization [56].
On the other hand, the nature of the physiologically relevant state
is less clear, particularly since the nature of the lipid environment can
easily change the thermodynamic balance between monomer and
dimer [57]. Early evidence suggested that rhodopsin functions as a
monomer [50,58,59], and more recent calorimetry experiments
indicate that in its native ROS membranes, rhodopsin is primarily
monomeric [60]. Furthermore, rhodopsin is capable of binding G
protein in its monomeric form [61–66].
As a result, the simulation community faces a signiﬁcant degree of
ambiguity: what state should we simulate? The vast majority of
simulations of GPCRs have considered only the monomeric form, but
is this a goodmodel for the in vivo behavior? This is a case where there
arguably is no ideal choice, at least given thepresent state of knowledge.
On one hand, we want to simulate the conditions that best resemble
those found experimentally in vitro and in vivo, which might argue in
favor of modeling dimers. However, modeling dimers brings with it a
number of major technical challenges. To start with, the simulation
system would need to be much larger, greatly increasing the
computational cost and signiﬁcantly reducing the length of the
trajectory that can be run. At the same time, the protein system is
larger, and thus will have slower ﬂuctuation modes that need to be
sampled, meaning that a longer trajectory would be required to acquire
equivalent statistical sampling. Generating good statistics is already a
signiﬁcant problem even formonomeric systems; althoughmany of the
longest all-atom trajectories ever run have been simulations of GPCRs
[40,67–71], careful analysis of the convergence has shown that the
microsecond-scale is almost certainly not long enough to draw ﬁrm
conclusions about many of the most interesting phenomena [72–74];
this will be discussed more extensively in Section 5.
The ﬁnal and perhaps most important challenge is due to the
simple fact that we do not know exactly what dimer (or higher-order
oligomer) to use. Although a number of researchers have constructed
models of dimers (for one example, see thework of Filizola,Weinstein
and coworkers [54,55,75–77] and others [78]), the fact remains thereis no crystal structure of a biologically relevant dimer, and the overall
record of homologymodeling and related efforts does not give us high
conﬁdence in the atomic level accuracy of such models. Thus, even if
the overall orientations of the monomers in the dimer are correctly
predicted, it is almost certain that many smaller-level details are not.
This in turn means that we must rely on the simulations to ﬁx the
problems for us, something not guaranteed to happen over the course
of a typical MD simulation. Indeed, the largest concern is that there
would be no real way to know if the starting structure was badly
ﬂawed: one could easily imagine a mis-packed dimer persisting for
hundreds of nanoseconds or longer.
Perhaps the only exception to this concern is the judicious use of
coarse-graining, which would extend the simulated time scales
enough to allow dimers to spontaneously form and dissociate under
equilibrium conditions. Indeed, Periole et al. used precisely this
approach very successfully [56]; each of their CG simulations
contained 16 rhodopsin molecules, and they systematically examined
the effect on oligomerization of varying the bilayer thickness.
Although their primary conclusion—hydrophobic mismatch greatly
increases the propensity of rhodopsin to oligomerize—is not an
enormous surprise, their work is an excellent example of the potential
for simulations to vividly illustrate biophysical principles. While their
model contains some very signiﬁcant approximations, including a
large number of restraints needed to keep the proteins near the native
state, it is wholly appropriate for the context in which it is used.
2.2. Investigations of the activation mechanism
One of the key questions in the rhodopsin ﬁeld (and the GPCR ﬁeld
in general) is the nature of the conformational changes that occur
during activation. The common model [23] of GPCR–G protein
function is that ligand binding from the extracellular face (or ligand
isomerization in the case of rhodopsin and retinal) drives a series of
conformational changes that propagate to the intracellular loops,
allowing the G protein trimer to bind and exchange GDP for GTP. As a
result, the G protein trimer dissociates into Gα and Gβγ subunits,
which in turn continue the signaling cascade by changing the
behavior of other proteins, for example adenylate cyclase.
Rhodopsin's structural changes during activation have been
studied extensively using a variety of techniques, including cysteine
scanning, EPR, NMR, and of course crystallography [27,79]. However,
there has been no crystal structure of a truly “active” GPCR, in part
because assessing activity in the context of a crystal is exceptionally
challenging, as it would arguably require crystallizing the full GPCR–G
protein complex. The closest examples to date are the crystal
structures of opsin on its own [14] and with a G protein fragment
bound [15].
As a result, the idea of usingMD simulations to directly explore the
activation mechanism is highly attractive, and efforts began shortly
after publication of the original rhodopsin crystal structure. Schulten
and co-workers published a 10 ns MD simulation of rhodopsin in a 1-
palmitoyl-2-oleoyl phosphatidylcholine (POPC) membrane, focusing
primarily on the retinal conformation and the relaxation of the side
chains in the binding pocket [80]. Unsurprisingly, they did not see
isomerization of Trp-2656.48, because the expected timescale for that
motion is signiﬁcantly longer. However, they did observe signiﬁcant
relocation of the retinal β-ionone ring, consistent with experimental
cross-linking data from Borhan et al. [81].
Lemaˆıtre et al. also explored the relaxation of the retinal post-
isomerization [82]. They performed a 10 ns dark-state simulation as
equilibration, then used steered MD to ﬂip the retinal torsion to the
trans state. They performed this ﬂipping three independent times, and
continued each simulation using conventional molecular dynamics
for 10 ns. The analysis focused on the details of the retinal
conformation, with careful comparison to solid state NMR experi-
ments from the same group. Although the calculations are very short
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trajectories: running three separate trajectories allowed the authors
to attempt to assess which of the conformational changes upon retinal
isomerization are critical parts of the activation mechanism.
Crozier et al. published a far more extensive simulation a few years
later [83]; by running for 150 ns (as opposed to 10 ns), they were able
to seemore of the protein's response to retinal isomerization. As in the
earlier work by Saam et al. [80], they observed that the ionone ring
approached Ala-1694.58, consistent with chemical cross-linking data
[81]; indeed, because the simulations were an order of magnitude
longer, they saw far more extensive motion in this regard, with the
ﬁnal separation between moieties around 9 Å. They also observed a
number of changes in helical tilts and kink angles, although in the
absence of a comparable dark-state simulation it is difﬁcult to know
how much of these changes is due to retinal isomerization.
Additionally, they saw the salt bridge break between Glu-1133.28
and the protonated Schiff base linking retinal to Lys-2967.43, as
expected during activation; see Section 2.2.1 for more discussion of
the salt bridge behavior.
Recently, Hornak et al. published a very interesting paper where
they used experimentally determined distance changes as energetic
restraints; applying these restraints in a simulation efﬁciently drove
rhodopsin toward the active Meta-II state [84]. Essentially, they used
magic angle spinning NMR to measure a set of interatomic distances
in the Meta-II state, primarily between carbons in the retinal and the
surrounding residues, and selected those that differed signiﬁcantly
from the crystal structure (PDB code 1U19). The selected distances
were used as additional restraints in a MD simulation of rhodopsin in
a bilayer-mimetic environment, in effect forcing it to become
consistent with the distances measured in the Meta-II state. This
allowed them to observe activation-like motions in very short
simulations, typically only a few ns in duration. In particular, they
observed signiﬁcant motion by helix 6, including disruption of the
ionic lock, and displacement of extracellular loop 2 (EL2), which forms
the “lid” enclosing the retinal binding pocket.
Although the method is very clever and the results largely
persuasive, there is a signiﬁcant reservation when interpreting this
kind of result, one common to most steered MD-type applications:
although the end points are reasonably well-determined, the path
taken during the trajectory is not guaranteed to be physiologically
relevant. In the cell, rhodopsin proceeds from dark state to Meta-I on
the microsecond scale, which then interconverts with Meta-II on the
millisecond scale (although much of this delay may be due to waiting
for the retinal Schiff base linkage to deprotonate, a necessary step for
Meta-II formation). Here, while we can be conﬁdent that the
restrained residues end up in conformations consistent with exper-
iment (and there are enough redundancies to strongly suggest that
the overall binding pocket changes are probably correct), it is not clear
that the remainder of the protein has “caught up.” That is, those
portions of the protein that are not altered by the experimental
restraints are rapidly perturbed by their application, and the
trajectories may not be long enough for them to relax, let alone
fully sample their equilibrium distributions. This is a major concern,
given that previous work has demonstrated that simulations two
orders of magnitude longer do not effectively converge the motions of
individual loops [72], let alone the protein as a whole (see Section 5
for further discussion).
2.2.1. Salt bridge to protonated Schiff base
In all of the rhodopsin crystal structures, the salt bridge between
Glu-1133.28 and the protonated Schiff base linkage between Lys-
2967.43 and the retinal is easily observed. Moreover, it is well known
that this interaction is at least partially disrupted during protein
activation. However, the exact mechanism by which this occurs has
been the subject of signiﬁcant controversy. Two competing models
exist for the role of two internal glutamates (Glu-1133.28 and Glu-181ECL2). One model, commonly referred to as the counterion switch
model [85], argues that the latter glutamate is protonated in dark-
state rhodopsin. After retinal isomerization, this proton is transferred
to Glu-1133.28, causing the salt bridge to break. After some
reorganization, the Schiff base forms a salt bridge to Glu-181ECL2,
signaling formation of the Meta-I state. By contrast, the complex
counterion model of Lu¨deke et al. [86] argues that both glutamates
are deprotonated throughout the process and that upon retinal
isomerization the Schiff base is effectively “shared” by the two
glutamates.
Röhrig, Rothlisberger and coworkers looked extensively at this
issue, systematically using Poisson–Boltzmann methods, classical
molecular dynamics, and mixed quantum/classical calculations
[87,88]. Their results were most consistent with the complex
counterion model, although the trajectories (particularly the QM-
MM ones) are fairly short. More recently, Ro¨hrig and Sebastiani
compared computed chemical shifts from a QM-MM trajectory to
experiments, but were unable to deﬁnitively determine which model
is more likely [89].
Recent advances in supercomputer technology have allowed
enormous increases in the scale of classical molecular dynamics
simulations [90,91]. Grossﬁeld and coworkers took advantage of these
gains to test both mechanisms directly, using classical MD methods
[67,92]. They performed two separate all-atom simulations of the
activation process. In the ﬁrst, designed to test the counterion switch
model, they began with an equilibrated model with Glu-181ECL2
protonated [39]; they induced the retinal torsion to ﬂip from cis to
trans and ran for 500 ns. They then stopped the simulation, manually
moved the proton from Glu-181ECL2 to Glu-1133.28, and continued
the simulation for an additional 1500 ns. To test the complex
counterion model, they similarly generated an equilibrated structure
with both glutamates in the charged state [40], ﬂipped the retinal
torsion, and ran for an additional 1500 ns. At the time of publication,
each of these simulations was longer than any previously published
all-atom trajectory of a membrane protein (or any other comparably
sized system).
These results indicated that both trajectories behaved essentially
the way their underlying models suggested they should. In particular,
Grossﬁeld et al. tracked the distances between the glutamate carbonyl
oxygens and the Schiff base nitrogen in both trajectories, as seen in
Fig. 1 [67]. In Part A, showing the counterion shift trajectory, the Glu-
1133.28–Schiff base salt bridge remains stable until the 500 ns point,
where the proton was moved to Glu-181ECL2. The interaction then
quickly breaks and, a few hundred nanoseconds later, is replaced by a
salt bridge to the now-charged Glu-181ECL2. In Part B, the complex
counterion trajectory, the salt bridge breaks after about 100 ns, and
the Schiff base gradually approaches Glu-181ECL2, although both
glutamates make strong interactions with it.
On one hand, these calculations strongly suggest that both models
approached something like the Meta-I state; in each case, the
glutamates did precisely what the underlying models said they
should. On the other, there is not enough information to determine
which of the two models is more likely correct. To do so, Mart´ınez-
Mayorga et al. compared the trajectories to solid state NMR results
[92]. Brown and coworkers previously reconstituted rhodopsin with
retinal speciﬁcally deuterated at particular methyl groups. From the
deuterium spectra, they predicted the orientation of the ionone ringin
the dark state and Meta-I [93,94] by ﬁnding the single conformation
that produced a theoretical line shape [95] most consistent with the
experimental spectrum. Mart´ınez-Mayorga et al. in a sense reversed
this approach, computing theoretical NMR spectra from the MD
trajectories by generating histograms of the methyl group orienta-
tions and using them to compute a weighted average spectrum. As
shown in Fig. 2, one trajectory—the complex counterion—produced
extremely accurate results, while the counterion switch trajectory
produced spectra that differ substantially from experiment,
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Fig. 1. Distance between internal glutamates and the Schiff base during simulations of rhodopsin activation. Part A shows the distances in the counterion switch simulation, while
Part B shows the complex counterion trajectory. The results were previously published in reference [67].
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applied to an ensemble of dark-state rhodopsin trajectories, the
results revealed that the ionone ring assumes two distinct orienta-
tions in the dark state [96]; the spectra computed from the full
ensemble matched the experiment signiﬁcantly better than did the
subset of the ensemble where the ionone assumed the orientation
found in the crystal structure (see Figs. 1d and 4 from reference [96]).
These results underscore the power of close collaboration betweenA
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Fig. 2. Comparison between theoretical and experimental deuterium spectra. The black line
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published in reference [92].simulation and experimental groups, and in particular the critical
importance of directly computing the experimental observable, rather
than simply comparing to the interpretation of the experimental
results.
2.2.2. Internal hydration changes upon activation
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s show experimental deuterium NMR spectra for the C5, C9, and C13 methyl groups of
ves show equivalent theoretical spectra computed from the distribution of angles found
hows the results for the complex counterion simulation. These results were previously
Fig. 3. Spontaneous ligand binding and subsequent activation-like structural changes in
the CB2 cannabinoid-2 receptor. The protein is shown as a ribbon model with the
intracellular face at the bottom, the 2AG ligand molecule is shown in a space-ﬁlling
view, and Trp-2586.48 is shown in red. Water oxygens within 15 Å of the protein
principal axis were histogrammed in 0.25 Å3 bins, smoothed with a 2 Å gaussian and
shown as blue surfaces contoured at half of bulk density. Data were originally published
in reference [97].
Fig. 4. Internal hydration of B2AR from molecular dynamics simulation. The average
protein structure from the simulation is shown in ribbon format. Water molecules were
histogrammed on a 0.25 Å3 grid, smoothed via convolution with a 2 Å gaussian, and
contoured at half of bulk density. Only waters within 15 Å of the protein principle axis
are shown. The underlying data was previously published in reference [68].
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that changes in the hydration of an already folded protein should play
a functional role, particularly for integral membrane proteins.
However, there is signiﬁcant experimental evidence that internal
hydration is important for the function of rhodopsin and perhaps
other GPCRs as well. For example, Mitchell, Litman, and coworkers
established that the presence of alcohols, sugars, and other osmolytes
in the surrounding medium signiﬁcantly alters the equilibrium
between the Meta-I and Meta-II states of rhodopsin [98–101],
suggesting that the active Meta-II state is less hydrated than Meta-I.
Moreover, the higher-resolution GPCR crystal structures all contain
numerous internal water molecules in functionally relevant locations
[5,102–105].
Still, it was a signiﬁcant surprise when Grossﬁeld et al. argued that
the internal hydration of rhodopsin increases dramatically during the
transition from the dark state to Meta-I [67]. In a 1500 ns simulation
modeling the complex counterion model of activation, they observed
the number of waters inside the protein increasing from 15–20 to
around 60; the exact number is sensitive to the criterion for what
constitutes the “inside” of the protein, but the trend is unmistakable.
Critically, they performed a dark-state simulation of comparable
length, where the hydration remained steady, precluding the
objection that the hydration changes were a failure of the simulation,
due to poor construction or ﬂaws in the force ﬁeld. The same paper
also contained a novel experimental conﬁrmation, via magic angle
spinning (MAS) 1H NMR. They saturated the water resonances and
observed attenuation of lipid hydrocarbon resonances, suggesting
magnetization transfer between water and lipid. However, the effect
was absent in lipid systems without rhodopsin, and was signiﬁcantly
stronger in the Meta-I state than in the dark or Meta-II states,
conﬁrming that the magnetization transfer is protein-mediated, via
long-lived protein–water interactions. The lifetime of waters inside
the protein cavity was typically on the timescale of 1–10 ns, although
a few water remained inside longer; this contrasts sharply with more
recent experiments suggesting residence times of seconds or longer
[103–105].
The simulation result was surprising enough to lack credibility on
its own, particularly given the unprecedented (at the time) length of
the trajectories; in the absence of experimental conﬁrmation, it would
likely have been dismissed. However, it challenged their experimental
collaborators to more carefully examine their experimental results on
attenuation of lipid signals with presaturation of proton resonances of
proteins, lipid, and water at various frequencies. This led to the
discovery that presaturation of the water resonance led to lipid
resonance attenuation that depended on rhodopsin's state [106]. It
was only when the simulations and experiments were combined that
credible interpretation became possible.
These results raise the question of generality: is this hydration
behavior unique to bovine rhodopsin–rhodopsin is after all an
unusual GPCR, or is it a general property of GPCRs in general? A
recent simulation of squid rhodopsin carefully analyzed the dynamics
of internal water molecules, and implicated these waters in the
activation mechanism [107], although the overall hydration levels
were much lower than in the above calculations, and the trajectory
was too short to see any activation-like ﬂuctuations.
Similar behavior was also seen in simulations of other, non-
rhodopsin, GPCRs. For example, microsecond-scale simulations of the
cannabinoid 2 (CB2) receptor by Hurst et al. also showed hydration
increases [97]; these calculations showed the spontaneous binding of
CB2's native ligand, 2-arachidonylglycerol (2AG), from the membrane
medium. Because CB2 needs to change protonation states as part of its
activation mechanism, the authors then “manually” protonated Asp-
1303.49 and Asp-2406.30, then continued the simulation for an
additional 2 μs. As shown in Fig. 3, the combination of 2AG binding
and sidechain protonation led to a series of activation-like events,
including repacking and partial disassembly of the interface betweenhelices 3 and 6 (where the ionic lock is usually found) and
isomerization of Trp-2586.48 . This in turn opens a continuous water
channel connecting the intracellular and extracellular domains via the
ligand binding pocket, allowing a dramatic increase in internal
hydration.
Furthermore, two simulations of B2AR also discussed the role of
internal hydration [68,108]; Fig. 4 is a visualization of the average
water density over the course of one of these trajectories [68]. The
water density is contoured at half of bulk density, showing that there
are several regions inside the protein that are perpetually hydrated. In
particular, the ligand binding pocket (the proteinwas simulated in the
apo form) ﬁlled with water during the equilibration period and
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central role in the “ionic lock” region, a highly conserved salt bridge
between Arg-1313.50 and Glu-2686.30 that breaks upon activation;
the simulation showed that the ionic lock frequently exists in a water-
bridged form, as opposed to a simple salt bridge. More recently,
Kaszuba et al. argued that water-ligand interactions in the B2AR
binding pocket contribute signiﬁcantly to B2AR selectivity for closely
related ligands [108], consistent with other analyses showing that
internal hydration strongly modulates ligand binding [109].
Overall, the preponderance of evidence indicates that GPCR
hydration is probably central to their functional ﬂuctuations; we
believe this will be a fruitful area for future study by both
computational and experimental means.
3. Simulations of GPCR–G protein interactions
The next critical stage in the molecular simulation of GPCRs is to
attack the full activation mechanism: the interaction with G protein
and subsequent dissociation of the trimer. Although going after this
problem computationally is attractive and could potentially yield a
wealth of functionally relevant information, this is an exceptionally
challenging problem. First, there is no high-resolution experimental
data describing the structure of the full complex, and the complex of
an integral membrane protein with a relatively large (trimeric)
soluble protein is a difﬁcult target for crystallography. Moreover, if we
assume that the dogma in the GPCR ﬁeld is correct and speciﬁc G
protein association only occurs when the GPCR is in its active state,
even the GPCR structure is not well known; this severely complicates
efforts to use docking and homologymodeling techniques to generate
a starting structure. Second, the resulting complex is extremely large
by current molecular dynamics standards (particularly once sufﬁcient
water to hydrate the G protein is included), which dramatically
increases both the computational cost per nanosecond of trajectory
time and the length of trajectory needed for statistically signiﬁcant
sampling of the relevant ﬂuctuations.
Despite these challenges, a few groups have attempted calcula-
tions involving the full GPCR–G protein complex. Raimondi et al. used
a combination of homology modeling, docking, and molecular
dynamics to examine the thromboxane A2 receptor bound to its
cognate G protein [110]. Although the paper is very ambitious, there
are some serious concerns in interpreting their results. First, as
discussed above, there is signiﬁcant uncertainty in their starting
structure, particularly since there is no crystal structure for the GPCR.
Second, the MD simulations themselves are extremely short, less than
10 ns, shorter than the correlation time for sampling protein
structures even in the case where no relaxation of the starting
structure is required. This is particularly concerning given their
reliance on essential dynamics methods in their analysis, because the
slow modes converge very slowly in GPCRs [72–74].
Last year, Sgourakis and Garcia published a calculation of truly
remarkable scope: an all-atom MD simulation of the rhodopsin–
transducin complex in an explicit lipid bilayer [111]. To our
knowledge, this represents the largest computational investment
ever made in a single calculation, a 400,000 atom system run for over
1 μs. The system is an attempt to model the interaction between dark-
state rhodopsin and its G protein partner, transducin, in the GDP-
bound state. This is an impressive attempt to attack an exceptionally
difﬁcult problem, one which reveals both the challenges and
opportunities involved with such calculations. For example, the
calculations revealed the dynamic nature of the interactions between
rhodopsin and the G protein α subunit, and explored the details of
intra- and inter-molecular salt bridge dynamics.
However, the simulation was not started from a crystal structure,
but rather a docking model [112,113]. This would be less of a concern
were the existence of the putative complex not so controversial;
although there is some evidence that rhodopsin can form speciﬁcinteractions with G proteins even with retinal in the inactivating 11-
cis conformation, this runs counter to the current dogma in the ﬁeld.
Furthermore, the interface between the two proteins repacks over the
course of the trajectory, forming a signiﬁcantly looser set of contacts
(see Fig. 2 of reference [111]). This could be interpreted to mean that
the complex is dynamic and samples a broad range of structures.
However, it could also mean that there are ﬂaws in the starting
structure. Unfortunately there is no obvious way to tell which of these
hypotheses is correct; proving the former case would likely require a
simulation 1 to 2 orders of magnitude longer. Given that the present
work is already heroic by current standards, this underlies the
challenges of performing all-atom calculations.
4. Simulations of other GPCRs
Although the GPCR MD literature emphasizes rhodopsin for
obvious historical reasons, the more recently published GPCR
structures have also been simulated extensively [68–70,108,114,
115] To our knowledge, the ﬁrst large-scale all-atom simulation of
B2AR, the second GPCR crystallized and solved, was published by
Huber et al. [114]; this very valuable paper is written as much as a
review of the implications of the new crystal structure as it is an
analysis of simulation. They chose to simulate the full chimeric protein
from the crystal—B2AR with T4 lysozyme inserted between helices 5
and 6 [9,10], in the presence of the inverse agonist ligand, carazolol;
they also performed simulations of the physiological ligand, adren-
aline. Interestingly, they mention that the internal hydration of the
protein increases in the adrenaline simulation, consistent with the
rhodopsin results discussed in Section 2.2.2.
The following year, Vanni et al. published a series of simulations
comparing the dynamics of B2AR and B1AR, focusing on the dynamics
of the ionic lock [115]. The ionic lock is a highly conserved salt bridge
between Arg3.50 and Glu6.30 thought to be crucial to maintaining the
inactive form of class A GPCRs; mutations to these residues tend lead
to constitutively active proteins [116,117]. As a result, the community
at large was surprised when the crystal structures of B2AR, B1AR, and
A2A all lacked this salt bridge. In the case of B2AR, the ionic bond is
displaced by a salt bridge to a symmetry-related T4 lysozyme
molecule, and more generally the accepted hypothesis is that the
modiﬁcations needed to induce the GPCRs to crystallize—the presence
of the antibody or fusion protein—altered the conformational
equilibrium in this region. Accordingly, it was very welcome to see
the careful analysis of the salt bridge in the Vanni et al. manuscript
[115]. They argue that the salt bridge's state depends on the
protonation state of another highly conserved residue, Asp2.50, even
though this residue is roughly 20 Å away; in their calculations, the salt
bridge is only stable when the aspartic acid residue is protonated.
Dror et al. performed a series of very long simulations of B2AR
(ﬁve≈1 μs, another over 2 μs), also focusing on the ionic lock [69].
They examined the role of the third intracellular loop (ICL3),
performing simulations with it clipped out, replaced with a model-
built version of the native loop, and with the full T4 lysozyme as seen
in the crystal structure. They found that ionic lock generally formed
stably in the clipped and native simulations, but the presence of the
lysozyme signiﬁcantly destabilized it. Moreover, when they simulated
a pair of constitutively active mutants with disrupted ionic locks, they
found that the helices in question (3 and 6) moved apart somewhat,
consistent with consensus models for activation.
The analysis of B2AR's internal hydration from Romo et al.
(another microsecond-scale simulation) [68] were discussed above
in Section 2.2.2. However, that work too discussed the state of the
ionic lock; they found that the lock existed in three distinct states:
closed, open, and water-bridged (where the two side chains each
formed hydrogen bonds to the same water molecule), and that the
three states rapidly inter-convert, on the nanosecond time scale. In
this simulation, the authors observed a single “activation-like” event,
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moving the sidechain of Glu-2686.30 far from its salt bridge partner.
Roughly 200 ns later, the helix returned to a more conventional α-
helical state, and the salt bridge resumed its previous noisy
association.
Finally, Lyman et al. conducted what is to our knowledge the only
large-scale simulation study of A2A [71]. They compared the binding
pocket ﬂuctuations of the protein with an antagonist bound to those
in the apo state, and found signiﬁcant conformational rearrangement
when the antagonist was removed, including isomerization of the
rotamer toggle (Trp-2466.48). However, the apo form of the protein is
signiﬁcantly stabilized by binding a cholesterol molecule between
helices 1, 2, 3, and 4; the equivalent region of rhodopsinwas predicted
to bind cholesterol in previous simulations [40].
5. Assessing statistical errors in simulations
There are two key questions one must ask of every molecular
dynamics paper in order to evaluate its questions: (1) Is the model
appropriate for the scientiﬁc question? (2) Are the statistics good
enough to draw conclusions? The ﬁrst question includes issues of
force ﬁeld quality (including the potential need for polarizable force
ﬁelds or even quantum mechanical models), system size and
composition, etc. While these issues are important, they have been
reviewed elsewhere numerous times, and in any event they are not
uniquely important in the study of GPCRs [118]. Indeed, as Zuckerman
and coworkers point out, it is often impossible to assess whether new
models are actually improvements without good sampling [119].
Moreover, many (perhaps most) of the longest all-atom molecular
dynamics trajectories performed in recent years have involved GPCRs
[40,42,43,67–69,92,120], and as a result they have been used as test
cases for sampling and convergence [72,73,119].
There are a number of ways of framing the problem of statistical
sampling: How do you compute error bars for quantities of interest?
How many independent samples does the simulation provide? What
are the relevant relaxation times for the system?
In some sense, these questions are tightly related: the correlation
times for the system (combined with the trajectory length) determine
the number of truly independent data points in the system, and the
statistics for independent, uncorrelated data sets are relatively simple.
In that case, the statistical uncertainty for a quantity A is well
estimated by the standard error
SE Að Þ = σ Að Þﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Nind
p ≈σ Að Þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
τ Að Þ
Tsim
s
ð1Þ
where SE is the standard error, σ is the standard deviation, Nind is the
number of independent samples, T is the correlation time, and Tsim is
the length of the simulation [73]. However, the challenge remains in
determining what Nind actually is.
When trying to assess the statistical uncertainty of a single scalar
quantity, the standard approach is block averaging [121]. In this
approach, the full trajectory is divided in M blocks, and the average
value for the quantity of interest (A) is computed for each block. The
blocked standard error is then
SEM Að Þ =
σM Að Þﬃﬃﬃﬃﬃ
M
p : ð2Þ
The true standard error for the full trajectory is estimated as the
limiting value as the individual blocks become long and thus
statistically independent. Although this method is simple to imple-
ment, there are certain difﬁculties in its use. First, as the length of the
individual blocks gets longer, the number of blocks necessarily
decreases, and as a result the standard error plot can get very noisy.
To some extent, if the noise is large enough that one cannot read off astandard error (or even determine if a plateau has been reached), this
should serve as an indicator that the simulation is far too short.
However, at the very least the need to determine a plateau
complicates the use of the block averaged standard error in an
automated way. Second, block averaging does not directly yield a
correlation time, and although one can estimate it using Eq. (1), this
estimate is typically low by perhaps a factor of 2 [73,122]. Third, if the
quantity of interest, A, is coupled to some other, far slower, quantity B,
it may not be immediately obvious from just the time series of A [73].
It should be noted that the term “block averaging” is often misused in
the literature to mean a standard deviation or standard error
computed from a single ﬁxed number of blocks, without any
veriﬁcation that this number of blocks is from the plateau region of
the SEM curve.
As a result, it is desirable to ﬁnd a better way to assess statistical
convergence, onewhich directly examines the largest scale (and likely
slowest) relevant modes in the system of interest. It is important to
include the term “relevant” in the previous sentence, because there
are always slowermodes that will not be captured in a simulation that
do not contribute signiﬁcantly to ensemble averages, for example
spontaneous protein unfolding under native conditions.
One interesting piece of work focusing on the convergence of
membrane proteins came from Fara´ldo-Gomez et al., who tried to
assess convergence by comparing two halves of 10 ns trajectories of a
number of proteins, including rhodopsin [123]. Among their in-
novations was their application of principal component analysis,
quantitatively comparing the ﬂuctuation spaces using a quantity
called the covariance overlap (originally developed by Hess
[124,125]):
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Later, Grossﬁeld et al. applied the same criterion to a set of 26
separate 100 ns trajectories [72]. The results strongly suggested that
100 ns (which at the time was a very long trajectory) was clearly not
long enough for the protein ﬂuctuations to converge well. Indeed, the
average covariance overlaps for pairs of trajectories, considering only
transmembrane region of the protein, was about 0.4, roughly the
same value found by Fara´ldo-Gomez et al. for trajectories an order of
magnitude shorter [123]. Furthermore, even individual loops, which
onemight suspect would be easier to sample than awhole protein, did
not appear converged, in large part because they have more complex
free energy surfaces with more distinct conformers that make
signiﬁcant contributions to the underlying ensemble.
More recently, several groups have performed microsecond-scale
simulations of rhodopsin [67,92] and B2AR [68,69], which currently
represents the state of the art. However, qualitative analyses suggest
that even these simulations do not produce particularly good
statistical sampling. For example, when Romo et al. computed all-
to-all RMSD maps—aligning each snapshot of the protein against all
others and color coding according to the RMS deviation—for long
trajectories for rhodopsin and B2AR a block-diagonal structure was
readily apparent, demonstrating the existence of substates persisting
on the time scale of 100 s of nanoseconds [68]. The absence of
signiﬁcant off-diagonal peaks indicated that as a rule each state was
visited only once. A similar conclusion was suggested by plots of the
trajectory projected onto the ﬁrst three principal components.
Although qualitative methods of this sort cannot demonstrate that
the statistics are good, they are valuable as easy-to-apply checks that
can tell when the statistics are not very good. In addition, Zuckerman
and coworkers applied one of their more sophisticatedmethods to the
same rhodopsin data; they performed a simple clustering procedure
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interconversion rate between states [119]. This in turn allows them
to directly assess the slower rates in the system, elegantly focusing on
the large-scale motions that directly control all other observables. We
believe that these assessments (both qualitative and quantitative)
should become a standard part of every simulation project, because a
careful analysis of the literature suggests an ongoing pattern of undue
optimism with respect to statistical sampling. Implementations of all
of these convergence assessment methods (and many other analysis
tools) are released as part of LOOS, an open source library of tools for
analyzing molecular dynamics simulations [126,127].
In contrast, it is often possible to apply far simpler models that are
not plagued by convergence problems. For example, network models,
which replace the complexity of all-atom force ﬁelds with harmonic
springs connecting neighboring atoms, have been successfully applied
to many protein systems [128,129], including GPCRs [130,131].
A recent paper shows that a well-tuned networkmodel calculation
represents protein ﬂuctuations as well as one would expect from an
MD simulation run for several hundred nanoseconds [74]. Given the
enormous difference in their computational cost 1–2 min on a laptop
for a network model versus weeks or months on a supercomputer for
the MD, these are models that clearly should be considered carefully
when designing computational projects.
6. Conclusions
Ever since the ﬁrst high-resolution structure of rhodopsin was
solved roughly 10 years ago, many groups have performed molecular
dynamics simulations designed to explore the structure, ﬂuctuations,
and function of GPCRs. This number has increased dramatically in the
last few years, with the publication of several new structures and
signiﬁcant increases in computational performance. As a result, many
of the longest simulations ever run have been performed on GPCRs in
the last few years. We have shown that simulations have made
signiﬁcant contributions in a number of areas, including protein–lipid
interactions, internal protein hydration, and the conformational
changes undergone during activation. In particular, close collabora-
tion between simulation and experiment (particular solid state NMR)
has proved to be exceptionally fruitful in generating exciting new
insights into GPCR function.
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